Summit Therapeutics (SMMT) Raises $500 Million Through Public Offering

Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the 12 best buy-the-dip stocks to invest in now. On June 10, an underwritten public offering of common stock valued at $500 million was initiated by Summit Therapeutics Inc. (NASDAQ:SMMT). The company stated in its announcement that 100% of the shares in this proposed transaction are being offered [...]